Literature DB >> 8521687

Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects.

E M Bifano1, T R Curran.   

Abstract

Limitations in the knowledge of the pathophysiology of anemia contribute to unfounded and liberal transfusion practices in the preterm infant and to uncertain risk-benefit ratios. Researchers have explored an array of strategies to minimize transfusions. Such strategies include collection and banking of autologous placental blood, administration of recombinant erythropoietin, innovations in blood banking practices, and improved definitions of the markers of anemia with more rigorous transfusion guidelines. This article presents an overview of these and other strategies that can be applied as part of an overall approach to limit effectively the number of transfusions in the newborn.

Entities:  

Mesh:

Year:  1995        PMID: 8521687

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  9 in total

1.  Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?

Authors:  A R Franz; F Pohlandt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  Functional echocardiographic assessment of myocardial performance in anemic premature infants: a pilot study.

Authors:  Maurizio Radicioni; Stefania Troiani; Daniele Mezzetti
Journal:  Pediatr Cardiol       Date:  2012-01-25       Impact factor: 1.655

Review 3.  Recommendations for transfusion therapy in neonatology.

Authors:  Gabriella Girelli; Stefano Antoncecchi; Anna Maria Casadei; Antonio Del Vecchio; Paola Isernia; Mario Motta; Daniela Regoli; Costantino Romagnoli; Gino Tripodi; Claudio Velati
Journal:  Blood Transfus       Date:  2015-07       Impact factor: 3.443

4.  Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?

Authors:  E Henry; R D Christensen; M J Sheffield; L D Eggert; P D Carroll; S D Minton; D K Lambert; S J Ilstrup
Journal:  J Perinatol       Date:  2014-09-25       Impact factor: 2.521

Review 5.  Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.

Authors:  Robin K Ohls
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor.

Authors:  John A Widness; Ashima Madan; Ligia A Grindeanu; M Bridget Zimmerman; David K Wong; David K Stevenson
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

7.  Factors affecting efficacy of packed red blood cell transfusion in neonates.

Authors:  Rakesh Kumar Pilania; Shiv Sajan Saini; Sourabh Dutta; Reena Das; Neelam Marwaha; Praveen Kumar
Journal:  Eur J Pediatr       Date:  2016-11-18       Impact factor: 3.183

8.  Effects of transfusions in extremely low birth weight infants: a retrospective study.

Authors:  Olga A Valieva; Thomas P Strandjord; Dennis E Mayock; Sandra E Juul
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

Review 9.  Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.

Authors:  Isabelle Von Kohorn; Richard A Ehrenkranz
Journal:  Clin Perinatol       Date:  2009-03       Impact factor: 3.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.